Cucurbitacin I (JSI-124) is a natural product that selectively inhibits the JAK2/STAT3 signaling pathway. It has demonstrated anti-cancer activity in both in vitro cell-based assays and in vivo animal models, making it a valuable research tool for oncology and signal transduction studies.